Hualan Biological Bacterin Inc. (301207.SZ)
CNY 18.51
(0.16%)
CNY 18.51
(0.16%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.41 Billion CNY | 31.2% |
| 2022 | 1.82 Billion CNY | -0.23% |
| 2021 | 1.82 Billion CNY | -24.59% |
| 2020 | 2.42 Billion CNY | 131.3% |
| 2019 | 1.04 Billion CNY | 30.68% |
| 2018 | 802.73 Million CNY | 181.75% |
| 2017 | 284.91 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 916.94 Million CNY | 157691.94% |
| 2024 Q1 | 34.22 Million CNY | -95.03% |
| 2024 Q2 | -584.95 Thousand CNY | -101.71% |
| 2023 Q1 | 144.76 Million CNY | -45.53% |
| 2023 FY | 2.39 Billion CNY | 31.2% |
| 2023 Q4 | 688.16 Million CNY | -56.13% |
| 2023 Q3 | 1.56 Billion CNY | 32299.78% |
| 2023 Q2 | 4.84 Million CNY | -96.66% |
| 2022 Q3 | 499.31 Million CNY | -52.26% |
| 2022 Q2 | 1.04 Billion CNY | 7074.62% |
| 2022 Q1 | 14.57 Million CNY | -96.66% |
| 2022 FY | 1.82 Billion CNY | -0.23% |
| 2022 Q4 | 265.77 Million CNY | -46.77% |
| 2021 Q1 | 10.98 Million CNY | -99.17% |
| 2021 Q4 | 436.97 Million CNY | -68.38% |
| 2021 Q3 | 1.38 Billion CNY | 1658155.1% |
| 2021 Q2 | -83.34 Thousand CNY | -100.76% |
| 2021 FY | 1.82 Billion CNY | -24.59% |
| 2020 FY | 2.42 Billion CNY | 131.3% |
| 2020 Q4 | 1.31 Billion CNY | 18.58% |
| 2020 Q3 | 1.11 Billion CNY | 84663.36% |
| 2020 Q2 | -1.31 Million CNY | 45.54% |
| 2020 Q1 | -2.41 Million CNY | 0.0% |
| 2019 FY | 1.04 Billion CNY | 30.68% |
| 2018 FY | 802.73 Million CNY | 181.75% |
| 2017 FY | 284.91 Million CNY | 0.0% |